| __timestamp | Lantheus Holdings, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 2917513 |
| Thursday, January 1, 2015 | 78634000 | 7878291 |
| Friday, January 1, 2016 | 75374000 | 8366794 |
| Sunday, January 1, 2017 | 92157000 | 6610381 |
| Monday, January 1, 2018 | 93326000 | 6556000 |
| Tuesday, January 1, 2019 | 103132000 | 6930000 |
| Wednesday, January 1, 2020 | 110171000 | 8758000 |
| Friday, January 1, 2021 | 218817000 | 10806000 |
| Saturday, January 1, 2022 | 233827000 | 9844000 |
| Sunday, January 1, 2023 | 267194000 | 13481000 |
Infusing magic into the data realm
In the ever-evolving landscape of the healthcare sector, understanding the financial dynamics of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Lantheus Holdings, Inc. and Soleno Therapeutics, Inc. from 2014 to 2023.
Lantheus Holdings has shown a remarkable upward trend, with SG&A expenses increasing by approximately 270% over the decade. This growth reflects their expanding operations and strategic investments. In contrast, Soleno Therapeutics, while maintaining a steady trajectory, has seen a more modest increase of around 360% in the same period, indicating a more conservative approach to scaling their operations.
The data highlights the contrasting strategies of these two companies, offering insights into their financial health and operational priorities. As the healthcare industry continues to grow, these trends provide a window into the future strategies of these key players.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Ascendis Pharma A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc. Trends and Insights
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs ImmunityBio, Inc.
Lantheus Holdings, Inc. and Novavax, Inc.: SG&A Spending Patterns Compared
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Bausch Health Companies Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared